1. Home
  2. KOSS vs NSRX Comparison

KOSS vs NSRX Comparison

Compare KOSS & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Koss Corporation

KOSS

Koss Corporation

N/A

Current Price

$4.13

Market Cap

39.3M

ML Signal

N/A

NSRX

Nasus Pharma Ltd. Ordinary Shares

HOLD

Current Price

$3.17

Market Cap

32.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KOSS
NSRX
Founded
1953
2019
Country
United States
Israel
Employees
N/A
7
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.3M
32.2M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
KOSS
NSRX
Price
$4.13
$3.17
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$19.67
AVG Volume (30 Days)
21.4K
52.6K
Earning Date
05-08-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
10.00
N/A
EPS
N/A
N/A
Revenue
$12,624,170.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.93
N/A
52 Week Low
$3.50
$1.98
52 Week High
$8.59
$9.99

Technical Indicators

Market Signals
Indicator
KOSS
NSRX
Relative Strength Index (RSI) 51.29 55.41
Support Level $3.75 $2.04
Resistance Level $4.72 $3.48
Average True Range (ATR) 0.21 0.25
MACD 0.01 0.02
Stochastic Oscillator 62.28 67.53

Price Performance

Historical Comparison
KOSS
NSRX

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: